Clinical trial
A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
NCT02395978 is registered in ClinicalTrials.gov with BioLite, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
- Lead sponsor
- BioLite, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 10, 2015
- Completion date
- March 18, 2019
- Enrollment
- 72 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.